You are viewing the site in preview mode

Skip to main content

Table 1 Comparison between study groups regarding basic demographic characteristics, indication for myomectomy and myoma size, location, preoperative hemoglobin and hematocrit

From: Blood loss from transverse versus longitudinal uterine incision in abdominal myomectomy: a randomized controlled trial

  Transverse uterine incision group (n = 25] Longitudinal uterine incision group (n = 24] p
Age (Yrs) Mean ± SD (95% CI) 28.84 ± 3.77 (27.2–30.3) 29.04 ± 4.68 (27.0–31.0) 0.86a
BMI (Kg/m2) Mean ± SD (95% CI) 24.36 ± 2.85 (23.1–25.5) 23.73 ± 2.45 (22.7–24.7) 0.41a
Parity 3 (1–4) 3 (2–5) 0.29b
Indication for myomectomy
 AUB 16 (64%) 15 (62.5%) 0.76c
 Pressure symptoms 5 (20%) 5 (20.8%)  
 Infertility 1 (4%) 0 (0%)  
 RPL 3 (12%) 4 (16.6%)  
Mean myoma size (mm) Mean ± SD (95% CI) 81.72 ± 14.03 (75.9–87.5) 82.29 ± 9.85 (78.1–86.4) 0.87d
Myoma localization    0.70c
 Type 3 3 (12%) 2 (8.33%)  
 Type 4 4 (16%) 4 (16.66%)  
 Type 5 8 (32%) 4 (16.66%)  
 Type 6 7 (28%) 10 (41.66%)  
 Type 7 0 0  
 Type 8 0 0  
Hybrid myomas (Type 2–5) 3 (12%) 4 (16.66%)  
Preoperative hemoglobin concentration (gm/dL) Mean ± SD (95% CI) 12.34 ± 0.97 (11.9–12.7) 12.63 ± 1.22 (12.1–13.1) 0.35d
Preoperative hematocrit (%) Mean ± SD (95% CI) 37.35 ± 3.01 (36.1–38.5) 38.25 ± 3.80 (36.6–39.8) 0.36d
  1. AUB, abnormal uterine bleeding; RPL, recurrent pregnancy loss
  2. aAnalysis using unpaired t-test
  3. bAnalysis using Mann–Whitney U-test
  4. cAnalysis using chi squared test
  5. dAnalysis using unpaired t-test with Welch’s correction
  6. eAccording to the Leiomyoma FIGO sub-classification system [18]